Diet Supplementation with Polyphenol-Rich Salicornia ramosissima Extracts Protects against Tissue Damage in Experimental Models of Cerebral Ischemia
Authors:
- Paula García-RodríguezPGPaula García-Rodríguez
- Feifei MaFMFeifei Ma
- Carmen del RíoCRCarmen del Río
- Marina Romero-BernalMRMarina Romero-Bernal
- Ana M. NajarANAna M. Najar
- María de la Luz Cádiz-GurreaMaría de la Luz Cádiz-Gurrea
- Francisco Javier Leyva-JimenezFrancisco Javier Leyva-Jimenez
- Laura RamiroLRLaura Ramiro
- Paloma Menéndez-ValladaresPMPaloma Menéndez-Valladares
- Soledad Pérez-SánchezSPSoledad Pérez-Sánchez
- Antonio Segura-CarreteroAntonio Segura-Carretero
- Joan MontanerJMJoan Montaner
Open Access
- 29 November 2022
- Vol. 14 (23) , 5077
Abstract
Strokes are the second most common cause of death worldwide and a leading cause of disability. Regular consumption of polyphenols has been shown to reduce the risk of suffering a cardiovascular event. For this reason, we have investigated the protective effect of Salicornia ramosissima, a seasonal halophyte that synthetizes high amounts of bioactive compounds, including polyphenols, in response to environmental stress. Aqueous, hydroalcoholic, and ethanolic extracts were prepared to investigate if dietary supplementation prior to ischemic challenge can prevent subsequent damage using two animal models. First, we screened the protective effect against hypoxia–reoxygenation in Drosophila melanogaster and observed that both ethanolic and hydroalcoholic extracts protected flies from the deleterious effects of hypoxia. Second, we confirmed the protective effect of S. ramosissima ethanolic extract against brain ischemia using the transient middle cerebral artery occlusion mice model. Four weeks of oral supplementation with the ethanolic extract before artery occlusion reduced infarct volume and lowered the plasma levels of the DNA peroxidant product 8-hydroxydeoxyguanosine. Phytochemical profiling of S. ramosissima ethanolic extract revealed 50 compounds. Thus, it represents a valuable source of bioactive compounds that show promising disease-modifying activities and could be further developed as an effective food supplement for the prevention or treatment of neurovascular disorders.Keywords
Funding Information
- Sara Borrell program funded by ISCIII (CD21/00148)
This publication has 61 references indexed in Scilit:
- α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysisThe American Journal of Clinical Nutrition, 2012
- RIGOR Guidelines: Escalating STAIR and STEPS for Effective Translational ResearchTranslational Stroke Research, 2012
- Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug DiscoveryPharmacological Reviews, 2011
- Neuroprotective Effect of Caffeoylquinic Acids from Artemisia princeps Pampanini against Oxidative Stress‐Induced Toxicity in PC‐12 CellsJournal of Food Science, 2011
- Evaluation of Salicornia herbacea as a Potential Antioxidant and Anti-Inflammatory AgentJournal of Medicinal Food, 2009
- Antioxidant and Antithrombus Activities of Enzyme-Treated Salicornia herbacea ExtractsAnnals of Nutrition and Metabolism, 2007
- Hypolipidemic effect of Salicornia herbacea in animal model of type 2 diabetes mellitusNutrition Research and Practice, 2007
- 1,026 Experimental treatments in acute strokeAnnals of Neurology, 2006
- Time Is Brain—QuantifiedStroke, 2006
- Chemical Characterization of Glycerolipids and Cerebrosides in a Halophytic Plant, Salicornia europaea LJournal of Oleo Science, 2004